ImmunoMet Therapeutics immunomet.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

ImmunoMet Therapeutics is a development-stage biotechnology company focused on utilizing cellular metabolism to develop anti-tumor and immuno-oncology therapies.

ImmunoMet Therapeutics is a development-stage biotechnology company focused on utilizing cellular metabolism to develop anti-tumor and immuno-oncology therapies.

Company (Alive / Active)

Phone: 346-772-0318

Fax:

2450 Holcombe Blvd

Houston, 77021
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ImmunoMet Therapeutics $10.2M Mar 7, 2017
See all 12 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ImmunoMet Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

BeneVir Biopharm

Rockville, Maryland, United States
AcquiredBeneVir is a privately held biopharmaceutical company founded in 2011 with offices and laboratories located in Rockville, MD. BeneVir is developing a novel platform of cancer immuno-therapies based on oncolytic viruses to help patients with hard-to-treat cancers. In 2012, BeneVir received two Small Business Innovation Research (SBIR) grants from the National Cancer Institute, which supported proof-of-concept studies. BeneVir's immunotherapies for cancer are designed to induce the immune system t...Show allLogin to see details

Neon Therapeutics

Cambridge, Massachusetts, United States
IPO / Went publicNeon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine allows Neon to develop multiple treatment modalities, including next-generation vaccines and T cell therapies targeting both personalized and shared neoantigens. Neon's lead program is a personalized neoantigen vaccine that builds upon years of research and development at the Broad Institute and Dana-Farber Cancer Institute, and...Show allLogin to see details
See all 12 competitors